The official Drugs@FDA dataset lists original submission 1 for NDA 022201 with status AP dated 2008-12-24, and names degarelix acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 076396 with status AP dated 2008-11-17, and names calcitonin salmon among the application record's active ingredients.
The Federal Register published notice E8-27179, attributed to FDA and its parent HHS department, on 2008-11-17. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SOMATULINE DEPOT,” and PeptideScanner's exact reviewed identity mapping connects the document to Lanreotide.
The Federal Register published notice E8-24356, attributed to FDA and its parent HHS department, on 2008-10-15. Its official title is “Pediatric Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.
The Federal Register published rule E8-24050, attributed to FDA and its parent HHS department, on 2008-10-09. Its official title is “Distribution of Certain Drug Products by Registered Blood Establishments and Comprehensive Hemophilia Diagnostic Treatment Centers That Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.
The official Drugs@FDA dataset lists original submission 1 for NDA 021795 with status AP dated 2008-05-08, and names desmopressin acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077329 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077330 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077331 with status AP dated 2008-03-04, and names octreotide acetate among the application record's active ingredients.
The official Drugs@FDA dataset lists original submission 1 for ANDA 077453 with status AP dated 2008-01-24, and names oxytocin among the application record's active ingredients.